Which funds bought or sold MRSH in Q3 2026?
Marsh & Mclennan Cos. 4 funds bought, 8 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$858M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Oakmark+$357M
- RBC+$212M
- Balyasny+$114M
- Schonfeld+$28M
- Wellington−$791M
- Geode−$247M
- Amundi−$217M
- Marshall Wace−$169M
- Capital Research−$152M
- Wells Fargo−$127M
- Arrowstreet−$122M
- TemasekOUT−$54M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (4)
Sold (8)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Wellington Asset manager | Trimmed-27.3% | −$791M | $2.1B |
| Geode Index giant | Trimmed-10.7% | −$247M | $2.1B |
| Amundi Asset manager | Trimmed-44.1% | −$217M | $275M |
| Marshall Wace Quant & multi-strategy | Trimmed-94.9% | −$169M | $9M |
| Capital Research Asset manager | Trimmed-8.1% | −$152M | $1.7B |
| Wells Fargo Bank & broker | Trimmed-29.5% | −$127M | $302M |
| Arrowstreet Quant & multi-strategy | Trimmed-17.1% | −$122M | $590M |
| Temasek Sovereign & pension | Sold out | −$54M | — |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.